<DOC>
	<DOCNO>NCT01968577</DOCNO>
	<brief_summary>Patients stable coronary disease undergo percutaneous coronary intervention may present periprocedural myocardial infarction define present creatine kinase-myocardial isoenzyme ( CK-MB ) elevation 3 time upper limit normal , cut periprocedural myocardial infarction PCI . Although percutaneous coronary intervention associate low rate complication , periprocedural myocardial infarction tout negative factor long-term clinical result . Several clinical , anatomical technical associate occurrence event . Although randomize controlled trial systematic review statin pre intervention target administration high-dose statin recommend surgery reduce risk periprocedural myocardial infarction , information impact maximum concentration plasma statin time percutaneous coronary intervention stable patient chronic statin use prevent periprocedural myocardial infarction elevation cardiac enzyme . The anti-ischemic effect statins percutaneous coronary intervention mainly determine statin -na√Øve patient patient acute coronary syndrome . In work , study impact peak plasma concentration statin time percutaneous coronary intervention study prospective randomize single center stable patient chronic statin divide two group . In group ( 1 ) Experimental ( n = 268 ) administer dose 40 mg rosuvastatin one six hour surgery group ( 2 ) control without rosuvastatin ( n = 268 ) . This range 1 6 hour time peak concentration rosuvastatin blood oral ingestion . The primary objective ass incidence periprocedural myocardial infarction creatine kinase three time upper normal limit hospital period secondary objective analyze elevation amount creatine kinase baseline .</brief_summary>
	<brief_title>Randomized Trial Creatine-kinase Leak After Rosuvastatin At Time Percutaneous Coronary Intervention</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients clinical sign stable angina ( Classification Canadian Cardiovascular Society 1 , 2 , 3 4 ) asymptomatic evidence ischemiainduced functional test indication elective PCI . Use statins period equal great 7 day report patient confirm medical prescription . Stent implantation de novo lesion native coronary artery consider eligible study The patient legal representative must sign consent form procedure , form contain detail research approve Ethics Committee Institution . Women childbearing potential use appropriate contraceptive measure pregnancy lactation . Values upper limit normal serum level CKMB mass harvest 24 hour prior procedure . Myocardial infarction &lt; 15 day . Renal insufficiency creatinine clearance &lt; 30 ml/min Patients know allergy , hypersensitivity contraindication follow : aspirin , heparin , clopidogrel , ticagrelor , statin iodinate contrast . Participation research influence serum level CKMB mass Have take fibrate 24 hour intervention . Use oral anticoagulant glycoprotein inhibitor day procedure . Evidence angiographic intracoronary thrombus target lesion . In stent restenosis , vein graft arterial . Complications procedure irreversible occlusion target vessel well branch great 1mm diameter , presence dissection compromise flow , cage branch reduce flow , coronary spasm abnormal blood flow distal embolization . Inability deploy stent . Use atherectomy technique . Patients randomize rosuvastatin administer prior procedure , guidewire stent reach ostium coronary target time le two hour exceed period six hour oral ingestion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Coronary angioplasty</keyword>
	<keyword>Myocardial infarction</keyword>
</DOC>